What Is Cell-Penetrating Peptide? Definition and What Research Reports

Definition

A cell-penetrating peptide (CPP), sometimes called a protein transduction domain or membrane-translocating sequence, is a short peptide — typically on the order of a few to roughly thirty amino acids — that is able to cross the plasma membrane of living cells and, in many designs, to carry a much larger attached molecule across with it. The label is functional rather than structural: any peptide that demonstrates this translocating behaviour in a cell or tissue model may be described as a CPP, regardless of its sequence family. Most described CPPs share one of two broad chemical characters — a strongly cationic sequence dominated by arginine and lysine residues, or an amphipathic sequence in which charged and hydrophobic residues are arranged so that one face of the folded peptide is greasy and the other is charged. Because "cell-penetrating peptide" names a behaviour, the category is open-ended and continues to expand as new sequences and synthetic backbones are characterised.

What Class of Molecule It Is, and Where the Term Comes From

CPPs sit within peptide chemistry rather than within any single therapeutic class. Historically the concept emerged from the observation that certain natural protein domains — notably the trans-activator of transcription domain of HIV-1 and the homeodomain of the Drosophila Antennapedia protein — could enter cells when applied from the outside, and that the short basic stretches responsible for this could be excised and reused on their own. From that starting point the field broadened in three directions: sequences derived from other natural proteins, including structural proteins of the extracellular matrix; chimeric sequences assembled from parts of different parent peptides; and fully synthetic designs, including non-natural backbones. Work on cell-penetrating peptide foldamers described these unnatural, shape-programmed oligomers as drug-delivery tools, illustrating that the category is no longer limited to sequences built from the standard twenty amino acids. On the natural-derivation side, a 2023 report described an elastin-derived VGVAPG fragment used to decorate a cell-penetrating peptide, which the researchers reported improved gene-delivery efficacy.

How the Term Is Used in Peptide Research

In the literature, "cell-penetrating peptide" is used in three fairly distinct ways.

• As a delivery vehicle. The most common usage: the CPP is covalently or non-covalently joined to a cargo that would not otherwise reach the cytoplasm — an oligonucleotide, a protein, a small molecule, a metal complex or a nanoparticle — and the conjugate is studied for uptake and activity.
• As an object of mechanistic study. Here the CPP itself is the subject, and the question is how it engages the membrane, which endocytic or direct-translocation routes it uses, and what surface molecules it recognises.
• As a design motif. Sequences may be described as "cell-penetrating peptide-like" when they borrow the cationic or amphipathic character of classical CPPs while serving another primary function, such as target binding or self-assembly.

Because usage is this broad, the phrase on its own carries no information about dose, route, species or safety — those details live in the individual paper. This page is for educational purposes only and is not medical advice; consult a licensed physician about anything relating to your own health.

What the Published Literature Reports

Published research on CPPs falls mostly into mechanism and cargo-delivery categories. On mechanism, a 2025 report in Cell described RNA-binding proteins and glycoRNAs forming domains on the cell surface that served as entry sites for cell-penetrating peptides — a finding that placed cell-surface RNA biology, rather than lipid interaction alone, into the picture of how these peptides are taken up. Complementary chemistry work reported that cell-penetrating peptide fragments could be activated by disulfide formation, describing a route by which an inactive fragment becomes a functional translocating species.

On the delivery side, the range of cargoes studied is wide. A 2022 study reported that a cell-penetrating peptide enhanced delivery and efficacy of phosphorodiamidate morpholino oligomers in mdx mice, a model used in muscular dystrophy research. A 2025 report described cell-penetrating peptide-grafted AAV2 capsids that the researchers reported improved retinal delivery after intravitreal injection. In formulation research, a 2020 study reported that a cell-penetrating peptide enhanced buccal absorption of insulin. Oncology-oriented chemistry has attached CPPs to active molecules directly: one group described cell-penetrating peptide-conjugated copper complexes investigated for redox-mediated anticancer activity, and another reported novel cell-penetrating peptide-conjugated proteasome inhibitors evaluated in anticancer and antifungal investigations.

Cargo classes described in the cited literature

Nanomaterial work has also used CPPs as surface ligands: a 2018 paper described the synthesis and study of cell-penetrating peptide-modified gold nanoparticles. More recent design work has blurred the line between vehicle and active agent — a 2025 report described cell-penetrating peptide-like anti-programmed cell death-ligand 1 peptide conjugates that self-assembled into nanoparticles studied for immunogenic photodynamic therapy, where the CPP-like character was part of the construct rather than a bolt-on carrier.

Tolerability in the Cited Work: What Studies Report

Safety characterisation of CPPs is study-specific and cannot be generalised across the category. Within the verified literature here, one 2020 paper framed its subject as a cell-penetrating peptide described as a high-safety anti-inflammation ingredient for cosmetic applications. The other cited reports were oriented toward delivery efficiency and activity rather than systematic toxicology; for example, the AAV2 capsid study reported improved retinal delivery via intravitreal injection as its primary observation. None of the cited papers establishes a human safety profile for CPPs as a class, and no dosing information for humans is described in them.

Limitations of the Term

1. It is a behaviour, not a compound. Two molecules both called CPPs may share almost no sequence and may enter cells by different routes.
2. Mechanism is still being revised. The identification of cell-surface domains formed by RNA-binding proteins and glycoRNAs as entry sites indicates that uptake models continue to change.
3. Findings are cargo- and model-bound. Results such as enhanced morpholino delivery in mdx mice describe one peptide, one cargo and one model, and do not transfer automatically to other constructs.
4. Most work is preclinical. The cited studies are chemistry, cell-culture and animal reports; they are research findings, not clinical recommendations.

References

• RNA-binding proteins and glycoRNAs form domains on the cell surface for cell-penetrating peptide entry (Cell, 2025)
• Cell-penetrating peptide enhanced insulin buccal absorption (International Journal of Pharmaceutics, 2020)
• Cell-penetrating peptide-conjugated copper complexes for redox-mediated anticancer therapy (Frontiers in Pharmacology, 2022)
• Cell-penetrating peptide-grafted AAV2 capsids for improved retinal delivery via intravitreal injection (Molecular Therapy: Methods & Clinical Development, 2025)
• Novel Cell-Penetrating Peptide Conjugated Proteasome Inhibitors: Anticancer and Antifungal Investigations (Journal of Medicinal Chemistry, 2020)
• A cell-penetrating peptide enhances delivery and efficacy of phosphorodiamidate morpholino oligomers in mdx mice (Molecular Therapy: Nucleic Acids, 2022)
• Cell-Penetrating Peptide Foldamers: Drug-Delivery Tools (ChemBioChem, 2019)
• Synthesis and study of cell-penetrating peptide-modified gold nanoparticles (International Journal of Nanomedicine, 2018)
• Cell-Penetrating Peptide Like Anti-Programmed Cell Death-Ligand 1 Peptide Conjugate-Based Self-Assembled Nanoparticles for Immunogenic Photodynamic Therapy (ACS Nano, 2025)
• Activation of cell-penetrating peptide fragments by disulfide formation (Amino Acids, 2020)
• Cell Penetrating Peptide as a High Safety Anti-Inflammation Ingredient for Cosmetic Applications (Biomolecules, 2020)
• Elastin-Derived VGVAPG Fragment Decorated Cell-Penetrating Peptide with Improved Gene Delivery Efficacy (Pharmaceutics, 2023)